[1] |
Odom DT, Zizlsperger N, Gordon DB, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science, 2004, 303: 1378-1381.
|
[2] |
Bagwell AM, Bailly A, Mychaleckyj JC, et al. Comparative genomic analysis of the HNF-4α transcription factor gene. Mol Genet Metab, 2004, 81: 112-121.
|
[3] |
Watt AJ, Garrison WD, Duncan SA. HNF4: a central regulator of hepatocyte differentiation and function. Hepatology, 2003, 37: 1249-1253.
|
[4] |
Chiang JY. Hepatocyte nuclear factor 4α regulation of bile acid and drug metabolism. Expert Opin Drug Metab Toxicol, 2009, 5: 137-147.
|
[5] |
Ishiyama T, Kano J, Minami Y, et al. Expression of HNFs and C/EBP alpha is correlated with immunocytochem ical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes. Cancer Sci, 2003, 94: 757-763.
|
[6] |
Hwang-Verslues WW, Sladek FM. Nuclear receptor hepatocyte nuclear factor 4 alphal1 competes with oncoprotein c-Myc for control of the P21/WAF1 promoter. Mol Endocrinol, 2008, 22: 78-90
|
[7] |
Lazarevieh NL, Cherenmova OA, Varga EV, et al. Progression of HCC in mice is associated with a down regulation in the expression of hepatocyte nuclear factors. Heptology, 2004, 39: 1038-1047.
|
[8] |
Ma S, Chan KW, Hu L, et al. Identification and characeterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology, 2007, 132: 2542-2556.
|
[9] |
Yang ZF, Ho DW, Ng MN, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell, 2008, 13: 153-166.
|
[10] |
Yin C, Lin Y, Zhang X, et al. Differentiation therapy of hepatocellular carcinoma In mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alPha gene. Hepatology. 2008, 48: 1528-1539.
|
[11] |
Spath GF, Weiss MC. Hepatocyte nuclear factor 4 provokes expression of pithelial marker gene, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol, 1998, 140: 935-946
|